Kemocarb 450mg

Oncologists prescribe it mainly for ovarian carcinoma and small cell lung cancer, given as a vein infusion.

Kemocarb 450mg Injection Ingredients and Usage

Kemocarb 450mg Injection contains carboplatin, a second generation platinum compound from the alkylating agent drug class. Alkylating agents attach platinum groups to tumour DNA, which blocks cancer cells from dividing and spreading. Doctors give the injection through a vein under close medical supervision.

Kemocarb treats advanced ovarian carcinoma, both as initial therapy and when the cancer returns after earlier chemotherapy. It also treats small cell lung cancer and supports treatment of head, neck, and other solid tumours. A nurse or oncologist always administers the dose, since patients must never self inject this medicine.

How Does Kemocarb 450mg Injection Work?

Kemocarb 450mg Injection works because carboplatin forms reactive platinum complexes once it enters the cancer cell. These complexes bind covalently to DNA and create intrastrand and interstrand crosslinks, which are abnormal bridges between DNA strands. The crosslinks block DNA copying and protein production inside the tumour.

Carboplatin acts in a cell cycle nonspecific way, so it damages cancer cells at any stage of their growth. The blocked DNA repair pushes the damaged cell into apoptosis, a controlled cell death. This platinum action shrinks tumours and slows the spread of cancer.

Kemocarb 450mg Injection Side Effects

Kemocarb 450mg Injection commonly causes blood and digestive effects, because chemotherapy harms rapidly dividing healthy cells. Bone marrow suppression is the main dose limiting effect, so doctors check blood counts before each cycle.

• Low platelet count, which raises bruising and bleeding risk

• Low white cells, which raises infection risk

• Anaemia and fatigue

• Nausea and vomiting

• Loss of appetite

• Peripheral neuropathy, meaning numbness or tingling in hands and feet

• Abnormal kidney or liver blood tests

• Hair thinning

Warnings

• Doctors must not give Kemocarb to patients with severe allergy to carboplatin, cisplatin, or other platinum compounds.

• Carboplatin causes thrombocytopenia, a drop in platelets that typically reaches its lowest point around 21 days after the dose.

• Patients with kidney disease need careful dosing, since the kidneys clear carboplatin and impaired function raises toxicity.

• Combining carboplatin with aminoglycoside antibiotics increases the risk of kidney damage and hearing loss.

• Carboplatin harms the unborn baby, so females of reproductive age must use effective contraception during treatment.

• Severe allergic reactions, including anaphylaxis, can occur within minutes, especially in patients with previous platinum exposure.

Kemocarb 450mg Injection Storage Conditions

Store Kemocarb 450mg Injection below 30°C in a cool, dry place, and protect the vial from direct light. Keep the vial in its original carton until use, since light and heat can degrade the carboplatin solution. Pharmacies and hospitals store this chemotherapy injection securely, away from children, because the drug is harmful if mishandled.